Page 217 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 217
Viral Hepatitis: Hepatitis A, B, D E Clinical (Except Therapy)
P0570 OCCULT HEPATITIS B INFECTION IN COMPLETELY
IMMUNIZED INDIVIDUALS NEGATIVE FOR ANTI-
HEPATITIS B CORE ANTIBODY
Ming-Wei Lai*, Tzou-Yien Lin, Chau-Ting Yeh, Taiwan
P0571 LIVER HISTOLOGY IN IMMUNETOLERANCE PHASE PATIENTS
WITH CHRONIC HEPATITIS BVIRUS INFECTION ACCORDING
TO DIFFERENT ALANINETRANSAMINASE LEVEL
Dengming He*, Qinghua Shang,Yuqi Zhang,Yong An, Qingqiang Yi,
Wei Zhang, Mingquan Ding, China
P0572 THE IMPACT OF HEPATITIS B VIRUS (HBV) INFECTION ON
PROGNOSIS OF PATIENTS WITH DIFFUSE LARGE B-CELL
LYMPHOMA AND THE OCCURRENCE OF HEPATITIS
FLARES AFTER WITHDRAWAL OF PROPHYLACTIC
ANTIVIRAL TREATMENT ON COMPLETION OF
CHEMOTHERAPY
Man Fai Law*, Hay Nun Chan, Ho Kei Lai, Chung Yin Ha, Celia Ng,
Yiu Ming Yeung, Sze Fai Yip, Hong Kong, China
P0573 A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND ePOSTERS
REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR
HBV, HCV AND HIV INFECTION
Nicola Coppola*, Loredana Alessio, Luciano Gualdieri,
Marantonietta Pisaturo, Caterina Sagnelli, Nunzio Caprio, Rita Maffei,
Mario Starace, Italo F. Angelillo, Giuseppe Pasquale, Evangelista Sagnelli, Italy
P0574 A SIGNATURE OF ELEVATED IMMUNE ACTIVATION IS
OBSERVED IN THE PERIPHERAL BLOOD OF VIRALLY
SUPPRESSED, HBEAG-NEGATIVE CHRONIC HBV PATIENTS
Christian Frey*, Adam Palazzo, Li Li, Menashe Elazar,
Ed PhamBen Fram, Thai Nguyen, Hwalih Han, Monica Elazar,
Jeffrey Glenn, Aijaz Ahmed, Stefan Pflanz, The United States
P0575 LIVER FIBROSIS IN TREATMENT-NAÏVE HIV-INFECTED
AND HIV/HBV-COINFECTED PATIENTS: ZAMBIA AND
SWITZERLAND COMPARED
Gilles Wandeler*, Lloyd Mulenga, Michael Vinikoor, Helen Kovari,
Manuel Battegay, Alexandra Calmy, Matthias Cavassini,
Enos Bernasconi, Patrick Schmid, Edford Sinkala, Benjamin Chi,
Matthias Egger, Andri Rauch, Switzerland
Vienna, Austria • April 22–26, 2015 217
P0570 OCCULT HEPATITIS B INFECTION IN COMPLETELY
IMMUNIZED INDIVIDUALS NEGATIVE FOR ANTI-
HEPATITIS B CORE ANTIBODY
Ming-Wei Lai*, Tzou-Yien Lin, Chau-Ting Yeh, Taiwan
P0571 LIVER HISTOLOGY IN IMMUNETOLERANCE PHASE PATIENTS
WITH CHRONIC HEPATITIS BVIRUS INFECTION ACCORDING
TO DIFFERENT ALANINETRANSAMINASE LEVEL
Dengming He*, Qinghua Shang,Yuqi Zhang,Yong An, Qingqiang Yi,
Wei Zhang, Mingquan Ding, China
P0572 THE IMPACT OF HEPATITIS B VIRUS (HBV) INFECTION ON
PROGNOSIS OF PATIENTS WITH DIFFUSE LARGE B-CELL
LYMPHOMA AND THE OCCURRENCE OF HEPATITIS
FLARES AFTER WITHDRAWAL OF PROPHYLACTIC
ANTIVIRAL TREATMENT ON COMPLETION OF
CHEMOTHERAPY
Man Fai Law*, Hay Nun Chan, Ho Kei Lai, Chung Yin Ha, Celia Ng,
Yiu Ming Yeung, Sze Fai Yip, Hong Kong, China
P0573 A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND ePOSTERS
REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR
HBV, HCV AND HIV INFECTION
Nicola Coppola*, Loredana Alessio, Luciano Gualdieri,
Marantonietta Pisaturo, Caterina Sagnelli, Nunzio Caprio, Rita Maffei,
Mario Starace, Italo F. Angelillo, Giuseppe Pasquale, Evangelista Sagnelli, Italy
P0574 A SIGNATURE OF ELEVATED IMMUNE ACTIVATION IS
OBSERVED IN THE PERIPHERAL BLOOD OF VIRALLY
SUPPRESSED, HBEAG-NEGATIVE CHRONIC HBV PATIENTS
Christian Frey*, Adam Palazzo, Li Li, Menashe Elazar,
Ed PhamBen Fram, Thai Nguyen, Hwalih Han, Monica Elazar,
Jeffrey Glenn, Aijaz Ahmed, Stefan Pflanz, The United States
P0575 LIVER FIBROSIS IN TREATMENT-NAÏVE HIV-INFECTED
AND HIV/HBV-COINFECTED PATIENTS: ZAMBIA AND
SWITZERLAND COMPARED
Gilles Wandeler*, Lloyd Mulenga, Michael Vinikoor, Helen Kovari,
Manuel Battegay, Alexandra Calmy, Matthias Cavassini,
Enos Bernasconi, Patrick Schmid, Edford Sinkala, Benjamin Chi,
Matthias Egger, Andri Rauch, Switzerland
Vienna, Austria • April 22–26, 2015 217
